Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 23, 2015
Event: Regulation FD Disclosure (Item 7.01). The company furnished an investor presentation (Exhibit 99.1) intended for use in meetings with investors or analysts on June 23, 2015, and subsequently.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an attached presentation for further details but does not summarize comparative period changes within the 8-K body.
Guidance, Outlook, and Risks
Management Commentary: The company is providing an investor presentation to update stakeholders. The content of this presentation is subject to modification.
Legal Disclaimer: The information furnished in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly referenced.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for specific financial guidance or operational updates.
- Note that the information in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Confirm the date of the presentation (June 2015) to ensure data currency relative to current market conditions.